A new gene involved in Parkinson's disease, a finding that may one day provide a target for a new drug to prevent and potentially even cure the debilitating neurological disorder has been identified by researchers.
A handful of genes have been identified in inherited cases of Parkinson's disease. The research team of Dr. Ming Guo, the study team leader, associate professor of neurology and pharmacology and a practicing neurologist at UCLA was one of two groups worldwide that first reported in 2006 in the journal Nature that two of these genes, PTEN-induced putative kinase 1 (PINK1) and PARKIN, act together to maintain the health of mitochondria - the power house of the cell that is important in maintaining brain health. Mutations in these genes lead to early-onset Parkinson's disease.
Drug Firm to Pay Huge Damages to Parkinsons Disease Sufferer
A French Parkinson's sufferer who turned into a gambler and thief, with compulsive homosexual urges thanks to the drugs he took, is all set to receive a huge compensation.
In this study, the team found that the new gene, called MUL1 (also known as MULAN and MAPL), plays an important role in mediating the pathology of the PINK1 and PARKIN.
The study has been published in eLife.
Source: ANI
Nose may Hold Key to Parkinson's Cure
A new study from Griffith University suggests that Parkinson's patients' nose may harbour a cure for the disease.
 Study Investigates Possibility of Readying the Brain to Combat Parkinson’s DiseaseResearchers are currently conducting a new study to determine whether early activation of a protein can help improve the brain's capacity. | Advertisement
|
Compound Formula Rehmannia Alleviates Levodopa-Induced Dyskinesia in Parkinson's Disease
Levodopa is the preferred treatment in the clinic for Parkinson's disease.
Recommended Reading
Latest Research News
